Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
Johnson
Jeremiah
J
Wang
Michael Y
MY
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors* / Q000502:physiology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab